Werewolf Therapeutics Inc (HOWL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,987 | 46,450 | 57,050 | 65,711 | 77,596 |
| TOTAL | $22,892 | $48,734 | $58,586 | $68,173 | $80,439 |
| Non-Current Assets | |||||
| PPE Net | 1,263 | 4,290 | 4,688 | 5,088 | 5,490 |
| Other Non-Current Assets | 0 | 4,998 | 6,122 | 6,366 | 6,637 |
| TOTAL | $1,263 | $9,288 | $10,810 | $11,454 | $12,127 |
| Total Assets | $24,155 | $58,022 | $69,396 | $79,627 | $92,566 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,939 | 3,569 | 754 | 1,078 | 2,774 |
| Accrued Expenses | 5,924 | 4,515 | 5,407 | 9,021 | 8,543 |
| TOTAL | $7,863 | $38,519 | $36,148 | $17,603 | $15,171 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 21,656 | 24,705 |
| Other Non-Current Liabilities | 0 | 7,301 | 8,443 | 10,754 | 11,226 |
| TOTAL | $N/A | $7,301 | $8,443 | $32,410 | $35,931 |
| Total Liabilities | $7,863 | $45,820 | $44,591 | $50,013 | $51,102 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,599 | 48,597 | 48,597 | 48,540 | 45,729 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -485,272 | -488,942 | -475,410 | -467,029 | -450,659 |
| TOTAL | $16,292 | $12,202 | $24,805 | $29,614 | $41,464 |
| Total Liabilities And Equity | $24,155 | $58,022 | $69,396 | $79,627 | $92,566 |